Synthetic data only. Never enter patient information; nothing is sent or stored. For clinicians. Not FDA cleared.For licensed clinicians. Educational demonstration on synthetic data. Never enter real patient identifiers or protected health information: everything runs in your browser and nothing is sent or stored. Clinical decision support only; not FDA cleared; physician review is required.
CPE-005 · Classification
LV-03: Steatosis without a cardiometabolic risk factor
Steatosis without a cardiometabolic risk factor. Evaluates hepatic steatosis documented.
Active rulePriority 4Liver engine v1.0.0
Condition
- hepatic steatosis documented
- no cardiometabolic risk factor present
- alcohol in the MASLD range
What it reports
- MASLD criteria are not met: consider other causes of steatosis (drugs, genetic and endocrine causes, rapid weight loss, malnutrition, lipodystrophy)
Diagnostic boundary
- Does not name the cause.
Evidence
- EV-DELPHI-2023Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6):1966-1986.Supports: MASLD criteria: steatosis plus at least one cardiometabolic risk factor and no other cause MetALD and alcohol-related liver disease separated by intake
Cases where this rule fires
Open a case to see this rule fire with real inputs, then change the values until it stops.
Try Biod in your practice
The Clinical Intelligence Layer — transforming fragmented clinical information into structured intelligence for clinician review and action.